Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 42595129.
- Also identified by DOI 10.1016/j.jaad.2026.08.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Relapse during ongoing JAK inhibitor therapy is not uncommon in real-world alopecia areata management, and rescue outcomes are heterogeneous and not reliably predicted by baseline clinical features or the selected rescue approach, supporting individualized management.